Skip to main content
Novartis
language-selector-globe Italia | it
Siti Novartis
  • Americas
  • Asia Pacific
  • Europe
  • International
  • Middle East & Africa
Argentina | Español
Brazil | Português
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Mexico | Español
United States | English
Australia | English
Bangladesh | English
Hong Kong S.A.R. | 繁體中文
India | English
Indonesia | English
Japan | 日本語
Korea | 한국어
Mainland China | 中文
Malaysia | English
Pakistan | English
Philippines | English
Singapore | English
Taiwan | 繁體中文
Thailand | ภาษาไทย
Austria | Deutsch
Belgium | Français
Belgium | Nederlands
Bulgaria | Български
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hungary | Magyar
Ireland | English
Italy | Italiano
Latvia | Latvian
Lithuania | Lithuanian
Netherlands | Nederlands
Norway | Norsk
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Serbia | Srpski
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Türkiye | Türkçe
United Kingdom | English
Global | English
Novartis Foundation | English
Egypt | English
Israel | עברית
Saudi Arabia | العربية
South Africa | English
language-selector-globe Italia
Choose Location
Americas Asia Pacific Europe International Middle East & Africa
Argentina | Español
Australia | English
Austria | Deutsch
Bangladesh | English
Belgium | Français
Belgium | Nederlands
Brazil | Português
Bulgaria | Български
Canada | English
Canada | Français
Central America | Español
Colombia | Español
Czech Republic | Česky
Czech Republic | English
Denmark | Dansk
Egypt | English
Estonia | Eesti
Finland | Suomalainen
France | Français
Germany | Deutsch
Greece | Ελληνικά
Hong Kong S.A.R. | 繁體中文
Hungary | Magyar
India | English
Indonesia | English
Ireland | English
Israel | עברית
Italy | Italiano
Japan | 日本語
Korea | 한국어
Latvia | Latvian
Lithuania | Lithuanian
Mainland China | 中文
Malaysia | English
Mexico | Español
Netherlands | Nederlands
Norway | Norsk
Global | English
Novartis Foundation | English
Pakistan | English
Philippines | English
Poland | Polski
Portugal | Português
Romania | Română
Russia | Русский
Saudi Arabia | العربية
Serbia | Srpski
Singapore | English
Slovakia | Slovensky
Slovenia | Slovenščina
Slovenia | English
South Africa | English
Spain | Español
Sweden | Svenska
Switzerland | Deutsch
Switzerland | Français
Taiwan | 繁體中文
Thailand | ภาษาไทย
Türkiye | Türkçe
United Kingdom | English
United States | English
    • Chi siamo 
      • Novartis in Italia 
      • La nostra missione 
      • Aree di attività 
        • Aree terapeutiche 
      • Diversity & Inclusion 
      • La nostra storia 
        • Le nostre origini 
        • Dal 1996 a oggi 
      • Persone 
      viale affollato Chi siamo
    • Per il paziente 
      • Il nostro impegno 
      • Alleati per la Salute 
        • Politiche Sanitarie e Socio Assistenziali 
        • A fianco di chi aiuta 
        • Benessere psicofisico 
        • News dalle Associazioni Pazienti 
        • Mini Lessons EUPATI 
        • Servizi e materiali utili 
        • Novartis Influencer Masterclass for Patients 
        • HTA - Nuovo regolamento 
        • Attualità 
      • Informazione e sensibilizzazione 
        • Campagne di informazione e sensibilizzazione 
      • Linea Embrace per la gestione delle malattie croniche 
      • Segnalazione effetti indesiderati 
      Un medico tiene le mani a un paziente Per il paziente
    • Sostenibilità 
      • Sostenibilità ambientale 
      • Etica e compliance 
      • Diversity & Inclusion 
      • Accesso e diritto alla salute 
      • Salute globale 
      • Reporting 
      • Indici ESG 
      Young patients waiting outside hospital in Rwanda Sostenibilità
    • Ricerca e innovazione 
      • Ricerca & sviluppo 
      • Nuove frontiere della R&S 
      • Novartis, la ricerca clinica in Italia nel 2023 
      • Open Innovation 
      • Professionisti della salute 
      dettaglio di una confezione di pillole Ricerca e innovazione
    • Lavora con noi 
      • Opportunità di lavoro 
      • Come lavoriamo 
      • Benessere 
      • Benefit 
      • Diversity & Inclusion 
      • Riconoscimenti e certificazioni 
      • La nostra cultura 
      Lavora con noi Lavora con noi
    • News 
      • Fatti e notizie 
      • Area riservata ai giornalisti 
      • Comunicati stampa 
      News News
    • Contatti 
    Homepage Italia Home
  1. Home
  2. Lavora con noi
  3. Cerca offerte di lavoro
  • Sort by Sort ascending
  • Titolo di lavoro
  • Site
  • Posizione
  • Divisione
  • Business Sort ascending
  • Area funzionale
  • Data di pubblicazione
Titolo di lavoro Site Posizione Divisione Business Sort ascending Area funzionale Data di pubblicazione
Director Data Science INSURGENTES Messico Operations CTS Data and Digital Set 03, 2024
Analyst Hyderabad (Office) India Operations CTS Marketing Apr 29, 2024
Cybersecurity Solutions Architect (Global Drug Development Team) Prague Repubblica Ceca Operations CTS Technology Transformation Apr 30, 2024
Snr Spec. DDIT US&I D&A Operations Hyderabad (Office) India Operations CTS Technology Transformation Apr 30, 2024
Senior Automation Engineer Carlsbad USA Operations CTS Technical Operations Mag 01, 2024
Analyst Telangana India Operations CTS Marketing Mag 02, 2024
Senior Analyst Hyderabad (Office) India Operations CTS Marketing Mag 03, 2024
Sr Specialist, MDM Operations Hyderabad (Office) India Operations CTS Technology Transformation Mag 06, 2024
Sr. Spec. DDIT ISC SecOps Cyber Tools Hyderabad (Office) India Operations CTS Technology Transformation Mag 07, 2024
Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Mag 07, 2024
Senior Analyst APLD Hyderabad (Office) India Operations CTS Marketing Mag 08, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Mag 09, 2024
Sr. Spec. DDIT IES Cloud Engineering Hyderabad (Office) India Operations CTS Technology Transformation Mag 09, 2024
Data Analyst Hyderabad (Office) India Operations CTS Marketing Mag 09, 2024
Assoc. Dir. DDIT APD ERP PlatformTech Se Hyderabad (Office) India Operations CTS Technology Transformation Mag 09, 2024
Finance Control and Compliance US Manager INSURGENTES Messico Finance CTS Audit e finanza Ott 08, 2024
General Accounting Manager INSURGENTES Messico Finance CTS Audit e finanza Ott 09, 2024
Learning & Talent Central Services Specialist INSURGENTES Messico People & Organization CTS Risorse umane Ott 14, 2024
Coordinator, Global Program Management and Portfolio Excellence INSURGENTES Messico Biomedical Research CTS Research & Development Ott 15, 2024
Procure to Pay Business Partner Management INSURGENTES Messico Finance CTS Audit e finanza Ott 16, 2024
Order to Cash RLT Sr. Specialist INSURGENTES Messico Finance CTS Audit e finanza Ott 16, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Mag 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Mag 20, 2024
Associate, Record-to-Report Head Office (Japan) (Pharmaceuticals) Giappone Finance CTS Audit e finanza Giu 26, 2024
Senior Specialist DDIT OPS Mfg Site IT Sasayama Giappone Operations CTS Tecnologia dell'informazione Lug 22, 2024
Manager, Financial Control & Compliance (FC&C) Head Office (Japan) (Pharmaceuticals) Giappone Finance CTS Audit e finanza Ott 06, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Mag 20, 2024
Analyst - SFE Products Hyderabad (Office) India Operations CTS Marketing Mag 20, 2024
Revenue Accounting Manager Shanghai (Shanghai) Cina Finance CTS Audit e finanza Lug 17, 2024
Associate Director, SUSE Linux Administrator Prague Repubblica Ceca Operations Corporate Technology Transformation Set 23, 2024
Associate Director, M&A Planning & Integration East Hanover USA Finance Corporate Audit e finanza Ott 17, 2024
Vice President, Head of R&D Legal, Americas Cambridge (USA) USA Legal Corporate Proprietà legali e intellettuali e conformità Ott 17, 2024
Executive Director, R&D Legal and FDA Regulatory Legal Lead East Hanover USA Legal Corporate Proprietà legali e intellettuali e conformità Ott 17, 2024
BPA Manager - Global Process Owner Hyderabad (Office) India Finance Corporate Audit e finanza Ott 15, 2024
Director, Sustainability & ESG Strategy (Health Equity / Access focus) Basel (City) Svizzera Corporate Affairs Corporate BD&L & Strategic Planning Ott 15, 2024
Senior Financial Analyst - Digital Finance Hyderabad (Office) India Finance Corporate Audit e finanza Ott 16, 2024
Juristisches Volontariat – Novartis Corporate Functions Basel (City) Svizzera Legal Corporate Others Set 26, 2024
Tax Manager m/w/d) Nuremberg (Non-Sales Force) (Novartis Pharma GmbH) Germania Finance Corporate Audit e finanza Ott 16, 2024
Corporate Tax Manager Amiria Egitto Finance Corporate Audit e finanza Mag 31, 2024
Global Digital FRA Automation Lead Hyderabad (Office) India Finance Corporate Audit e finanza Giu 20, 2024
Manager- Data Privacy Review and Remediation Telangana India Ethics Risk & Compliance Corporate Proprietà legali e intellettuali e conformità Ott 10, 2024
Senior Product Manager, Digital Finance Barcelona Gran Vía Spagna Finance Corporate Audit e finanza Ott 01, 2024
Expert Analyst – Management Reporting Prague Repubblica Ceca Finance Corporate Audit e finanza Ott 08, 2024
Manager- Data Privacy Review and Remediation Selangor Malaysia Ethics Risk & Compliance Corporate Proprietà legali e intellettuali e conformità Ott 14, 2024
Investor Relations Executive Director East Hanover USA Finance Corporate Audit e finanza Ago 28, 2024
Senior Accountant, Tax Shanghai (Shanghai) Cina Finance Corporate Audit e finanza Ago 29, 2024
Financial Analyst - SoD Ops Hyderabad (Office) India Finance Corporate Audit e finanza Set 17, 2024
Associate Director, Data Privacy, Digital & AI East Hanover USA Ethics Risk & Compliance Corporate Proprietà legali e intellettuali e conformità Set 04, 2024
Associate Director, US Federal and State Tax Reporting East Hanover USA Finance Corporate Audit e finanza Set 06, 2024
Associate Director ERC Risk&Operations, Corporate Functions Selangor Malaysia Ethics Risk & Compliance Corporate Proprietà legali e intellettuali e conformità Ago 29, 2024

Pagination

  • ‹ Previous page
  • 1
  • …
  • 36
  • 37
  • 38
  • 39
  • 40
  • 41
  • 42
  • › Next page

Novartis Farma S.p.A Viale Luigi Sturzo, 43 - 20154 Milano (MI) tel. 02/9654.1
C.F. 07195130153 / P.IVA 02385200122

Novartis Italia

Naviga
  • Per il paziente
  • Professionisti della salute
  • Sostenibilità
  • News
  • Lavora con noi
  • Novartis nel mondo
News
  • Archivio news
  • Fatti & Notizie
  • Comunicati Stampa
  • Area riservata ai giornalisti
Siti web Novartis
  • Sito del gruppo
Footer Bottom
© 2024 Novartis Italia
  • Avvertenze legali
  • Privacy Policy
  • Contatti
  • Impostazioni cookie
  • Mappa del sito
  • Accessibilità
Elenco siti Novartis
Questo sito è destinato a utenti residenti in Italia